Cognitive Behavioral Therapy for Insomnia Reduces Hypnotic Prescriptions
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective This study determined whether cognitive behavioral therapy for insomnia (CBT-i) decreased the need for sleep medications and produced better treatment outcomes than pharmacotherapy alone. Methods We reviewed data from patients with insomnia in the outpatient clinic of a general hospital between 2009 and 2015. We compared 41 patients who received five sessions of CBT-i with 100 age- and sex-matched patients who received pharmacotherapy only. We evaluated the change in prescription for sleep (i.e., antidepressants, hypnotics, and others) between the first and last visits using repeated measures analysis of variance (ANOVA). Clinical global impressions and completion status at the last visit were assessed using the chisquare test. Results We found a significant decrease in the prescription rate and the dosage of hypnotics among patients who received CBT-i when compared with control patients. There was no significant change in the dosage of antidepressants between the two groups. Achievement of case closure was better in the CBT-i group at the trend level. Clinical global impression at the last visit was not significantly different. Conclusion These results show that CBT-i reduces the need for hypnotics among insomnia patients. Our results indicate that CBT-i offers additional benefits beyond improving sleep characteristics and thus provides another reason for recommending CBT-i as a first-line treatment for insomnia.
Abstract
Objective This study determined whether cognitive behavioral therapy for insomnia (CBT-i) decreased the need for sleep medications and produced better treatment outcomes than pharmacotherapy alone. Methods We reviewed data from patients with insomnia in the outpatient clinic of a general hospital between 2009 and 2015. We compared 41 patients who received five sessions of CBT-i with 100 age- and sex-matched patients who received pharmacotherapy only. We evaluated the change in prescription for sleep (i.e., antidepressants, hypnotics, and others) between the first and last visits using repeated measures analysis of variance (ANOVA). Clinical global impressions and completion status at the last visit were assessed using the chisquare test. Results We found a significant decrease in the prescription rate and the dosage of hypnotics among patients who received CBT-i when compared with control patients. There was no significant change in the dosage of antidepressants between the two groups. Achievement of case closure was better in the CBT-i group at the trend level. Clinical global impression at the last visit was not significantly different. Conclusion These results show that CBT-i reduces the need for hypnotics among insomnia patients. Our results indicate that CBT-i offers additional benefits beyond improving sleep characteristics and thus provides another reason for recommending CBT-i as a first-line treatment for insomnia.
참고문헌 (42)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders (DSM-V)" (2013), American Psychiatric Association Publishing
- Cho HJ, "Sleep disturbance and longitudinal risk of inflammation: moderating influences of social integration and social isolation in the Coronary Artery Risk Development in Young Adults (CARDIA) study", Brain Behav Immun, 46, pp.319~326 (2015)[DOI]
- Kim TH, "Associations between actigraphy-assessed sleep, inflammatory markers, and insulin resistance in the Midlife Development in the United States (MIDUS) study", Sleep Med, 27-28, pp.72~79 (2016)[DOI]
- Lee E, "Persistent sleep disturbance: a risk factor for recurrent depression in community-dwelling older adults", Sleep, 36, pp.1685~1691 (2013)
- Kallestad H, "Impact of sleep disturbance on patients in treatment for mental disorders", BMC Psychiatry, 12, pp.179~ (2012)[DOI]
- Tobaldini E, "Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases", Neurosci Biobehav Rev, 74, pp.321~329 (2017)[DOI]
- Morin CM, "Prevalence of insomnia and its treatment in Canada", Can J Psychiatry, 56, pp.540~548 (2011)[DOI]
- Roth T, "Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria", International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey, 2011, pp.69, 592~600
- Ohayon MM, "Epidemiology of insomnia: what we know and what we still need to learn", Sleep Med Rev, 6, pp.97~111 (2002)[DOI]
- Clinical Psychiatry Eleventh Edition, "Kaplan and Sadock's Synopsis of Psychiatry. Behavioral Sciences", pp.2014, Sadock BJ
- Qaseem A, "Management of chronic insomnia disorder in adults: a clinical practice guideline from the American college of physicians", Ann Intern Med, 165, pp.125~133 (2016)[DOI]
- Schutte-Rodin S, "Clinical guideline for the evaluation and management of chronic insomnia in adults", J Clin Sleep Med, 4, pp.487~504 (2008)
- Olfson M, "Benzodiazepine use in the United States", JAMA Psychiatry, 72, pp.136~142 (2015)[DOI]
- Smink BE, "The relationship between benzodiazepine use and traffic accidents: a systematic literature review", CNS Drugs, 24, pp.639~653 (2010)[DOI]
- Wagner AK, "Benzodiazepine use and hip fractures in the elderly: who is at greatest risk", Arch Intern Med, 164, pp.1567~1572 (2004)[DOI]
- Morin CM, "Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial", JAMA, 281, pp.991~999 (1999)[DOI]
- Morin CM, "Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial", JAMA, 301, pp.2005~2015 (2009)[DOI]
- Irwin MR, "Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age", Health Psychol, 25, pp.3~14 (2006)[DOI]
- Morin CM, "Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial", JAMA, 281, pp.991~999 (1999)[DOI]
- Edinger JD, "Overcoming Insomnia: A Cognitive-Behavioral Therapy Approach, Therapist Guide. Second Edition, 2 edition" (2014), Oxford University Press
- Morin CM, "Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial", JAMA, 301, pp.2005~2015 (2009)[DOI]
- Ray WA, "Benzodiazepines of long and short elimination half-life and the risk of hip fracture", JAMA, 262, pp.3303~3307 (1989)[DOI]
- Wiegand MH, "Antidepressants for the treatment of insomnia: a suitable approach?", Drugs, 68, pp.2411~2417 (2008)[DOI]
- Hayasaka Y, "Dose equivalents of antidepressants: evidence-based recommendations from randomized controlled trials", J Affect Disord, 180, pp.179~184 (2015)[DOI]
- Wagstaff AJ, "Tianeptine: a review of its use in depressive disorders", CNS drugs, 15, pp.231~259 (2001)[DOI]
- Inada T, "Psychotropic dose equivalence in Japan", Psychiatry Clin Neurosci, 69, pp.440~447 (2015)[DOI]
- Kaldo V, "Guided internet cognitive behavioral therapy for insomnia compared to a control treatment - A randomized trial", Behav Res Ther, 71, pp.90~100 (2015)[DOI]
- Mitchell MD, "Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review", BMC Fam Pract, 13, pp.40~ (2012)[DOI]
- Herings RM, "Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life", Arch Intern Med, 155, pp.1801~1807 (1995)[DOI]
- Blom K, "Three-year followup of insomnia and hypnotics after controlled internet treatment for insomnia", SLEEP, 39, pp.1267~1274 (2016)[DOI]
- Belleville G, "Hypnotic taper with or without self-help treatment of insomnia: a randomized clinical trial", J Consult Clin Psychol, 75, pp.325~335 (2007)[DOI]
- Taylor HL, "Effectiveness of a CBT intervention for persistent insomnia and hypnotic dependency in an outpatient psychiatry clinic", J Clin Psychol, 71, pp.666~683 (2015)[DOI]
- O'Connor K, "Cognitive-behavioural, pharmacological and psychosocial predictors of outcome during tapered discontinuation of benzodiazepine", Clin Psychol Psychother, 15, pp.1~14 (2008)[DOI]
- Charles M, "Chronic insomnia", Lancet, 379, pp.1129~1141 (2012)[DOI]
- Becker PM, "Pharmacologic and nonpharmacologic treatments of insomnia", Neurol Clin, 23, pp.1149~1163 (2005)[DOI]
- Kasasbeh E, "Inflammatory aspects of sleep apnea and their cardiovascular consequences", South Med J, 99, pp.58~67 (2006)[DOI]
- Knutson KL, "Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus", Arch Intern Med, 166, pp.1768~1774 (2006)[DOI]
- Davidson JR, "Sleep disturbance in cancer patients", Soc Sci Med, 54, pp.1309~1321 (2002)[DOI]
- Foral P, "Medication-induced sleep disturbances", Consult Pharm, 26, pp.414~425 (2011)[DOI]
- Vitiello MV, "Cognitive behavioral therapy for insomnia improves sleep and decreases pain in older adults with co-morbid insomnia and osteoarthritis", J Clin Sleep Med, 5, pp.355~362 (2009)
- Johnson JA, "A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors", Sleep Med Rev, 27, pp.20~28 (2016)[DOI]
- Harvey AG, "A cognitive model of insomnia", Behav Res Ther, 40, pp.869~893 (2002)[DOI]